11 May 2021
AstraZeneca vaccine's single dose reduces death risk by 80%: Data
A single dose of AstraZeneca's COVID-19 vaccine results in an 80% less risk of death from the viral infection, Public Health England (PHE), the executive agency of the UK department of health, said Monday, citing data from the vaccine's rollout.
02 May 2021
COVID-19 vaccine formulas shouldn't be shared with India: Bill Gates
It's a terrible time to be a publicist for Bill Gates. The billionaire, who the mainstream media celebrates as a philanthropist, is being criticized for his stance on vaccine patents.
15 Apr 2021
Denmark becomes first European country to permanently drop AstraZeneca vaccine
Even as vaccines became the world's biggest hope against the highly contagious coronavirus, Denmark has stopped using the one made by British-Swedish pharma giant AstraZeneca.
08 Apr 2021
AstraZeneca serves legal notice to Serum Institute over vaccine delays
Serum Institute of India (SII), the manufacturer of the coronavirus vaccine Covishield, has been served a legal notice by the drug maker AstraZeneca over delays in vaccine supply, the company's CEO Adar Poonawalla confirmed in an interview earlier this week.
03 Apr 2021
UK: Seven blood-clotting-related deaths in 18mn AstraZeneca COVID-19 vaccine recipients
On Saturday, the United Kingdom's medical regulator said that seven people—out of more than 18 million recipients of the Oxford-AstraZeneca jab for COVID-19 in the country—died of unusual blood clots.
02 Apr 2021
Facing delay in securing vaccines, Lanka temporarily suspends COVID-19 jabs
Sri Lanka has temporarily halted its COVID-19 vaccination program as there was a delay in securing more AstraZeneca vaccines from the Serum Institute of India (SII), a top health minister has said.
31 Mar 2021
Germany halts AstraZeneca vaccine use for under-60s over clot fears
Germany will allow general use of the AstraZeneca coronavirus vaccine only for people aged above 60 years, imposing restrictions on younger people taking the jab after several severe cases of blood clots were reported, the German government said on Tuesday.
25 Mar 2021
Amid growing cases, India temporarily halts export of AstraZeneca's vaccine
Facing a sudden spike in coronavirus cases, India has halted the export of the AstraZeneca vaccine for now, Reuters reported quoting two sources. Millions of doses of the vaccine are being manufactured by the Pune-based Serum Institute of India (SII), the world's biggest vaccine-maker.
22 Mar 2021
AstraZeneca says US trial data shows vaccine 79% effective
AstraZeneca says advanced trial data from a US study on its COVID-19 vaccine shows it is 79 percent effective.
19 Mar 2021
AstraZeneca's coronavirus vaccine dubbed safe; European countries to resume vaccination
A chunk of European countries, that had earlier stopped using AstraZeneca's coronavirus vaccine over blood clot concerns, will resume the vaccination drive after the jab got the support of the continent's top medical regulator.
16 Mar 2021
Why European countries are halting the AstraZeneca shot
The largest and most influential European countries, like Germany, France, and Italy, have paused the rollout of coronavirus vaccine, developed by the University of Oxford and British-Swedish pharma giant AstraZeneca over blood clot fears.
13 Mar 2021
Looking at adverse effects: India on concerns over AstraZeneca vaccine
India is constantly looking at all the adverse side effects as it conducts a massive coronavirus vaccination program, a top medical expert said today.
12 Mar 2021
Use of AstraZeneca's coronavirus vaccine suspended in Denmark, Norway, Iceland
Denmark, Norway, and Iceland have temporarily suspended the use of the coronavirus vaccine developed by British-Swedish pharma giant AstraZeneca as several patients developed blood clots after getting the jab.
01 Mar 2021
AstraZeneca has sold its stake in Moderna for $1 billion
British pharmaceutical company AstraZeneca Plc has sold its 7.7 percent stake in Moderna Inc., the American pharmaceutical giant, for more than $1 billion, according to a report in The Times.
25 Feb 2021
COVID-19 vaccines: SII to play huge role in mass production
British-Swedish pharmaceutical giant AstraZeneca and US pharmaceutical major Novavax have told lawmakers that they are ready to scale up their production of COVID-19 vaccines in partnership with the Serum Institute of India.
16 Feb 2021
WHO authorizes AstraZeneca's COVID-19 vaccine for emergency use
The World Health Organization has granted an emergency authorization to AstraZeneca's coronavirus vaccine, a move that should allow the UN agency's partners to ship millions of doses to countries as part of a UN-backed program to tame the pandemic.
10 Feb 2021
South Africa scraps AstraZeneca vaccine, will give J&J jabs
South Africa will give the unapproved Johnson & Johnson vaccine to its frontline healthcare workers beginning next week as a study to see what protection it provides from COVID-19, particularly against the variant dominant in South Africa, Health Minister Zweli Mkhize announced on Wednesday.
04 Feb 2021
UK begins world's first alternate dosing COVID-19 vaccine trial
Health chiefs in the UK on Thursday began what they have described as the world's first clinical trial of patients who will receive different COVID-19 vaccines for their first or second dose, to detect its impact on immunity against coronavirus.
03 Feb 2021
Oxford/AstraZeneca first jab cuts COVID-19 transmission substantially: UK study
According to a new Oxford University study, the first dose of the two-dose Oxford/AstraZeneca vaccine can cut coronavirus transmissions by around 67 percent and therefore, have a substantial effect on controlling the spread.
03 Feb 2021
Russia's coronavirus vaccine approved for use in Mexico
Mexico approved the Russian coronavirus vaccine Sputnik V for use on Tuesday, just hours after the publication of early results of an advanced study saying it is about 91 percent effective.
02 Feb 2021
South Africa welcomes first delivery of COVID-19 vaccines
South Africa gave a hero's welcome on Monday to the delivery of its first COVID-19 vaccines - one million doses of the AstraZeneca vaccine produced by the Serum Institute of India.
30 Jan 2021
Sri Lanka: No adverse reactions so far following vaccination
No adverse reactions or side-effects have so far been reported by those who were vaccinated in Sri Lanka on Friday with Oxford-AstraZeneca vaccine Covishield, provided by India, health officials said on Saturday.
29 Jan 2021
Johnson & Johnson's one-shot COVID-19 vaccine shows 66% strong efficacy
Johnson & Johnson's (J&J) much-awaited COVID-19 vaccine has reportedly exhibited strong protection against the virus.
26 Jan 2021
Diplomats, including from Pakistan and China, offered coronavirus vaccines
After starting its vaccination drive on January 16, New Delhi has offered made-in-India vaccines to diplomatic corps, including to those from Pakistan and China.
25 Jan 2021
Top French advisor talks third lockdown as coronavirus cases surge
France will have to enforce a third national lockdown to handle the worrying surge of coronavirus cases, the country's top medical advisor Prof Jean-Francois Delfraissy said on Sunday.
22 Jan 2021
After SII fire, BCG, rotavirus vaccine production to be hit
Thursday's fire at Pune's Serum Institute of India will impact the production of BCG and rotavirus vaccines in the future, the company said on Friday.
21 Jan 2021
Five killed in Serum Institute fire; Maharashtra government orders probe
The Maharashtra government has ordered a probe into the fire that broke out at the Serum Institute of India in Pune on Thursday, killing at least five people.
21 Jan 2021
Pune: Fire breaks out at Serum Institute of India
On Thursday afternoon, a fire broke out at the Terminal 1 gate of Serum Institute of India, Pune.
21 Jan 2021
Coronavirus: PM Modi, CMs to get vaccinated in second phase
Prime Minister Narendra Modi, 70, would be getting the coronavirus vaccine shot in the second phase of the drive launched last week, reports said on Thursday.
19 Jan 2021
Maldives to become first foreign country to receive Covishield doses
Maldives is set to become the first foreign country to receive COVID-19 vaccines from India. The Asian country will reportedly receive a consignment of Covishield doses on Wednesday.
17 Jan 2021
Meet India's frontline workers who received first COVID-19 vaccine shots
On Saturday, India launched its COVID-19 vaccination drive, inoculating 1.91 lakh people on the first day alone.
11 Jan 2021
Vaccine transport from SII to start from January 11/12
With the COVID-19 vaccination drive in India set to roll out on January 16, transportation of the Covishield vaccine from the Serum Institute of India's facility in Pune, is likely to start from the evening of January 11 or January 12, sources involved in logistics planning said on Sunday.
10 Jan 2021
Delhi identifies 89 sites for COVID-19 vaccination drive: Health Minister
The Delhi government has identified 89 sites for the COVID-19 vaccination drive in the national capital, Health Minister Satyendar Jain said on Sunday.
08 Jan 2021
Severe side-effects after COVID-19 vaccine: What are your legal options?
India is looking forward to launching a massive COVID-19 vaccination drive with two vaccines that have been granted emergency use authorization (EUA).
08 Jan 2021
Coronavirus vaccine consignment awaits government nod for take-off from Pune
On Thursday night, the Pune Airport was prepared to airlift vials of coronavirus vaccine, the first such exercise in India's massive inoculation drive.
07 Jan 2021
COVID-19 vaccine transport to start soon; government readies plan
The central government has prepared a detailed draft for the transport of vaccines across India ahead of a nationwide roll-out.
07 Jan 2021
Ahead of nationwide exercise, COVID-19 vaccine dry run in Haryana
A dry run of the COVID-19 vaccine roll-out was conducted in Haryana on Thursday, a day before the exercise will be conducted across India.
05 Jan 2021
SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
The Serum Institute of India (SII) and Bharat Biotech have taken a joint pledge to ensure global access of the COVID-19 vaccines developed by them.
04 Jan 2021
COVAXIN is 200% safe: Bharat Biotech MD on efficacy concerns
Bharat Biotech MS Krishna Ella on Monday said the company has "tremendous experience" in developing vaccines and their vaccine, COVAXIN, is "200% safe."
04 Jan 2021
Bharat Biotech allowed COVAXIN trials on children aged 12+
Hyderabad-based pharmaceutical company Bharat Biotech has been allowed to conduct clinical trials for its COVID-19 vaccine on children above the age of 12.